PT - JOURNAL ARTICLE AU - Keskinocak, Pinar AU - Oruc, Buse Eylul AU - Baxter, Arden AU - Asplund, John AU - Serban, Nicoleta TI - The Impact of Social Distancing on COVID19 Spread: State of Georgia Case Study AID - 10.1101/2020.04.29.20084764 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.29.20084764 4099 - http://medrxiv.org/content/early/2020/05/03/2020.04.29.20084764.short 4100 - http://medrxiv.org/content/early/2020/05/03/2020.04.29.20084764.full AB - Importance As the COVID19 spread in the US continues to grow, local and state officials face difficult decisions about when and how to transition to a “new normal.”Objective Project the number of COVID19 infections and resulting severe outcomes, and the need for hospital capacity under social distancing, particularly, shelter-in-place and voluntary quarantine.Design We developed an agent-based simulation model to project the infection spread. We populated the model using COVID19-specific parameters for the natural history of the disease and data from Georgia on agents’ interactions and demographics.Setting The simulation study covered a six-month period, testing different social distancing scenarios, including baselines (no-intervention or school closure only) and combinations of shelter-in-place and voluntary quarantine with different timelines and compliance levels. The outcomes are compared at the state and community levels.Main Outcomes The number and percentage of cumulative and daily new and symptomatic and asymptomatic infections, hospitalizations, and deaths; COVID19-related demand for hospital beds, ICU beds, and ventilators.Results The combined intervention of shelter-in-place followed by voluntary quarantine reduced peak infections from 180,000 under no intervention and 120,000 under school closure, respectively, to below 80,000, and delayed the peak from April to June or later. Increasing shelter-in-place duration from four to five weeks yielded 3–14% and 4–6% decrease in cumulative infection and fatality rates, respectively. Regardless of the shelter-in-place duration, increasing voluntary quarantine compliance decreased daily new infections from almost 80,000 to 50,000, and decreased cumulative infection rate by 50%. The total number of fatalities ranged from 6,150 to 17,900 under different scenarios. Peak infection date varied across scenarios and counties; on average, increasing shelter-in-place duration delayed the peak day by 7 days across counties. The peak percentage is similar across rural and urban counties. Region D is estimated to have the highest COVID19-related healthcare needs with 7,357 hospital beds, 1,141 ICU beds, and 558 ventilators.Conclusions and Relevance Shelter-in-place followed by voluntary quarantine substantially reduce COVID19 infections, healthcare resource needs, and severe outcomes; delay the peak; and enable better preparedness. Time of the peak is projected to vary across locations, enabling reallocation of health system capacity.Question How social distancing strategies impact the spread of COVID19?Findings Extending shelter-in-place by one week delays the peak by about 8 days but it does not significantly reduce the peak. High compliance with voluntary quarantine following shelter-in-place reduces the peak by 40% in Georgia.Meaning There needs to be a very strong public messaging about social distancing when shelter-in-place is lifted, to achieve a better match between healthcare capacity and demand, considering different peak times across the communities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWilliam W. George and by the Virginia C. and Joseph C. Mello endowments at Georgia Tech. No external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe manuscript utilizes publicly available data sources and model parameters from the literature. All sources are cited in the manuscript. https://dph.georgia.gov/covid-19-daily-status-report http://data.census.gov http://data5.ctpp.transportation.org https://github.com/nytimes/covid-19-data